Korean Firms Repurpose FDA-approved Drug for Rheumatoid Arthritis Treatment
The BioSpectrum website reported that Standigm Inc, an artificial intelligence-based drug discovery company and SK Chemicals Co, Ltd, a life science and green chemicals company have announced that they have successfully found a new rheumatoid arthritis indication for an FDA-approved drug and have filed a patent. This is the first successful result of
Comments Off on Korean Firms Repurpose FDA-approved Drug for Rheumatoid Arthritis Treatment • Read this story »
More Articles
Medical Forces Join to Develop Novel Antibody Treatments for Cancer
The OA Online website reported that HiFiBio Therapeutics announced the formation of Victa Biotherapeutics, a joint venture with Dr. Vikas P. Sukhatme. The new open-innovation collaboration will look to expand on the immuno-oncology research pioneered by Dr. Sukhatme. This new joint venture and
Comments Off on Medical Forces Join to Develop Novel Antibody Treatments for Cancer • Read this story »
Open Innovation in Pharma & Biotec
The Fleming website announced that the 4th Annual Conference on Open Innovation in Pharma & Biotec will be held Nov. 17-18 in Vienna, Austria. The call to the conference noted that recent analysis of the current state of open innovation in Pharma & Biotech has revealed a higher successrate for
Comments Off on Open Innovation in Pharma & Biotec • Read this story »
Open Innovation in the Electric Vehicle Marketplace
An article on the Rocky Mountain Institute website notes that alone, automakers can only do so much to alleviate customer uncertainty—and can do even less to overcome the cultural and systemic challenges that electric vehicless face. However, through collaboration with governments, utilities, financiers,